These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23456877)

  • 1. Cerebral malaria: protection by erythropoietin.
    Bienvenu AL; Picot S
    Methods Mol Biol; 2013; 982():315-24. PubMed ID: 23456877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin prevents the death of mice during cerebral malaria.
    Kaiser K; Texier A; Ferrandiz J; Buguet A; Meiller A; Latour C; Peyron F; Cespuglio R; Picot S
    J Infect Dis; 2006 Apr; 193(7):987-95. PubMed ID: 16518761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artesunate-erythropoietin combination for murine cerebral malaria treatment.
    Bienvenu AL; Ferrandiz J; Kaiser K; Latour C; Picot S
    Acta Trop; 2008 May; 106(2):104-8. PubMed ID: 18359468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can erythropoietin be used to prevent brain damage in cerebral malaria?
    Casals-Pascual C; Idro R; Picot S; Roberts DJ; Newton CR
    Trends Parasitol; 2009 Jan; 25(1):30-6. PubMed ID: 19008152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium berghei ANKA: erythropoietin activates neural stem cells in an experimental cerebral malaria model.
    Core A; Hempel C; Kurtzhals JA; Penkowa M
    Exp Parasitol; 2011 Feb; 127(2):500-5. PubMed ID: 21044627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain mitochondrial function in a murine model of cerebral malaria and the therapeutic effects of rhEPO.
    Karlsson M; Hempel C; Sjövall F; Hansson MJ; Kurtzhals JA; Elmér E
    Int J Biochem Cell Biol; 2013 Jan; 45(1):151-5. PubMed ID: 22903021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria.
    Wiese L; Hempel C; Penkowa M; Kirkby N; Kurtzhals JA
    Malar J; 2008 Jan; 7():3. PubMed ID: 18179698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner.
    Harder Y; Amon M; Schramm R; Contaldo C; Metzkow E; Matzen A; Rücker M; Vollmar B; Menger MD
    Surgery; 2009 Apr; 145(4):372-83. PubMed ID: 19303985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali.
    Picot S; Bienvenu AL; Konate S; Sissoko S; Barry A; Diarra E; Bamba K; Djimdé A; Doumbo OK
    Malar J; 2009 Jul; 8():169. PubMed ID: 19630971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
    Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
    Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier.
    Medana IM; Chan-Ling T; Hunt NH
    Am J Pathol; 2000 Mar; 156(3):1055-65. PubMed ID: 10702421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On recombinant human erythropoietin preventing the death of mice during cerebral malaria.
    Lackner P; Helbok R; Schmutzhard E
    J Infect Dis; 2007 May; 195(9):1391; author reply 1391-2. PubMed ID: 17397015
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin treatment alleviates ultrastructural myelin changes induced by murine cerebral malaria.
    Hempel C; Hyttel P; Staalsø T; Nyengaard JR; Kurtzhals JA
    Malar J; 2012 Jun; 11():216. PubMed ID: 22741599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effect of one large dose of erythropoietin against cardiac and cerebral ischemic injury occurring during cardiac surgery with cardiopulmonary bypass: a randomized double-blind placebo-controlled pilot study.
    Joyeux-Faure M; Durand M; Bedague D; Protar D; Incagnoli P; Paris A; Ribuot C; Levy P; Chavanon O
    Fundam Clin Pharmacol; 2012 Dec; 26(6):761-70. PubMed ID: 21929528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting glutamine metabolism rescues mice from late-stage cerebral malaria.
    Gordon EB; Hart GT; Tran TM; Waisberg M; Akkaya M; Kim AS; Hamilton SE; Pena M; Yazew T; Qi CF; Lee CF; Lo YC; Miller LH; Powell JD; Pierce SK
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13075-80. PubMed ID: 26438846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?
    Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P
    Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescein angiography findings strengthen the theoretical basis for trialling neuroprotective agents in cerebral malaria.
    Maude RJ; Beare NA
    Trends Parasitol; 2009 Aug; 25(8):350-1. PubMed ID: 19635680
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.
    Higgins SJ; Kain KC; Liles WC
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):803-19. PubMed ID: 21905788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral malaria--clinical manifestations and pathogenesis.
    Hora R; Kapoor P; Thind KK; Mishra PC
    Metab Brain Dis; 2016 Apr; 31(2):225-37. PubMed ID: 26746434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview: pathophysiology and management of cerebral malaria.
    Looareesuwan S
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():155-65. PubMed ID: 1364863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.